Inhalation

INH0225

Issue link: https://www.e-digitaleditions.com/i/1532011

Contents of this Issue

Navigation

Page 35 of 38

This section is presented as a service to Inhalation’s readers. Content is provided by Inhalation’s advertisers. No product endorsement or preference is intended. 34 February 2025 Inhalation WHITE PAPERS AND WEBINARS These white papers and webinars from Inhalation's advertisers are presented as a service to readers. Content is provided by the companies listed. No product endorsement or preference is intended. Copley Scientific Our expert-led webinars are now on-demand! Access trusted OINDP and pharmaceutical insights anytime, making education convenient and flex- ible, even if you missed live sessions. www.copleyscientific.com Proveris Laboratories Dedicated partner in success— a specialized CRO with unpar- alleled expertise in OINDPs. Committed to helping clients nav- igate the complexities of product development with confidence. www.proveris.com Intertek Webinar: Development of Drug-Nebuliser Combination Products - Formulation and Device Consid- erations to Ensure Success. Watch on-demand & download the insightful Q&A now: www.intertek.com S-Matrix USP <1604>, official in June 2024, contains important changes to results obtained from ACI and NGI impactor data. Click the Fusion Inhaler Testing link below for more on this topic. www.smatrix.com MSP, a Division of TSI ® Whether you are testing nebulizers, or seeking more efficient clean- ing methods, the Next Generation Impactor (NGI+) opens new possi- bilities for improving your inhalation testing processes. www.tsi.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0225